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Abstract 
Autophagy is an evolutionarily conserved process used for removing surplus and 
damaged proteins and organelles from the cytoplasm. The unwanted material is 
incorporated into autophagosomes that eventually fuse with lysosomes leading to the 
degradation of their cargo. The fusion event is mediated by the interaction between 
the Qa-SNARE syntaxin-17 (STX17) on autophagosomes and the R-SNARE 
VAMP8 on lysosomes. 
Cells deficient in lysosome membrane-associated protein-2 (LAMP-2) have increased 
numbers of autophagosomes but the underlying mechanism is poorly understood. By 
transfecting LAMP-2 deficient and LAMP-1/2 doubly deficient mouse embryonic 
fibroblast (MEF) with a tandem fluorescent-tagged LC3 we observed a failure of 
fusion between the autophagosomes and the lysosomes that could be rescued by 
complementation with LAMP-2A. Although we observed no change in expression 
and localization of VAMP8, its interacting partner STX17 was absent from 
autophagosomes of LAMP-2 deficient cells. Thus LAMP-2 is essential for STX17 
expression by the autophagosomes and this absence is sufficient to explain their 
failure to fuse with lysosomes. The results have clear implications for situations 
associated with a reduction of LAMP-2 expression. 
Introduction 
Macroautophagy (hereafter autophagy) is characterized by unique double membrane 
vacuoles that transfer surplus and damaged proteins and organelles into lysosomes 
for degradation. This maintains the quality of the cytoplasm and is critical for cellular 
homeostasis and resistance to stress. Autophagy is essential for tissue remodeling 
during embryogenesis and for innate and adaptive immune responses.  The efficiency 
of autophagy declines with age and this contributes to diseases found in the elderly, 
including degenerative neurological disorders, autoimmune and inflammatory 
diseases, and tumors. 45 
 
In mammalian cells, autophagy is mainly regulated by the level of amino acids and 
insulin that converge to mTOR, the main regulator of nutrient signaling. 43 This 
process is initiated at the endoplasmic reticulum (ER)-mitochondria contact sites with 
the development of open-ended cisterna, phagophores, which incorporate 
cytoplasmic components including organelles by engulfment26 and cargo-specific 
loading. 10 Phagophore initiation is regulated by three multiprotein complexes: the 
ULK1 complex comprised of ULK1, autophagy-related protein 13 (Atg13), Atg101 
and FIP200; the Vps 34 complex that includes Beclin1, Atg14L and Vps34; and the 
Atg16/Atg5/Atg12 complex.  The final stage of phagophore development involves 
Atg3 and the incorporation of LC3 (Atg8). LC3 occurs in two forms: an 
unconjugated cytoplasmic form, LC3-I, and a conjugated (lipidated) form, LC3-II, 
that integrates into the phagophore membrane. 47 LC3 persists after membrane 
closure and leads to the formation of the autophagosomes 45 whereas other Atg 
proteins and early phagophore components dissociate from mature autophagosomes. 
38 Consequently, LC3-I and LC3-II in cell lysates have been used to monitor 
autophagy. 36 Eventually autophagosomes fuse with lysosomes to become 
autolysosomes. 
 
Fusion of autophagosomes with lysosomes is essential for autophagic flux and the 
mechanisms responsible are beginning to be understood. 44 They involve the 
interactions between numerous proteins including some specific for 
autophagosome/lysosome fusion and others involved in vesicular fusion more 
generally. Selected vesicles and organelles are brought together both by diffusion and 
motor-mediated transport and then tethered to each other by specific molecular 
interactions. This facilitates the fusion event that occurs when a v-SNARE (N-
ethylmaleimide-sensitive factor attachment protein receptor) in the membrane of one 
vesicle engages a t-SNARE to form a bundle of four parallel core SNARE domains 
that approximates the two bilayers and precipitates fusion. 60 Tethering 
autophagosomes to lysosomes critically involves the Rab7 effector ORP1L and RILP 
which recruits the dynein-dynactin motor and interacts with the homotypic fusion and 
protein sorting (HOPS) complex that consists of six subunits vacuole sorting proteins 
(VPS). 1, 29, 61 This interaction is tightly regulated by the cholesterol sensor ORP1L 
which under low cholesterol conditions prevents the recruitment of HOPS to Rab7-
RIPL and therefore tethering of the membrane. 61 The HOPS complex will then tether 
lysosomes to autophagosomes by cross-linking Rab7 on lysosomes to syntaxin 17 
(STX17) on autophagosomes 33 in a process augmented by Atg14. 1, 11 STX17 is also 
the Qa-SNARE essential for autophagosome-lysosome fusion. After incorporation 
into the autophagosome membrane, STX17 recruits the Qbc-SNARE synaptosomal-
associated protein 29 (SNAP-29) and the complex is then bound by oligomeric Atg14 
which primes its interaction with the R-SNARE VAMP8 on the lysosomes and 
induces fusion (Fig. S1). 11, 30 Various other proteins have been implicated in 
autophagosome/lysosome fusion but their contribution is unclear. 44 These include 
lysosome membrane protein-2 (LAMP-2), a protein with a defined role in 
phagolysosome biogenesis as demonstrated by a failure of opsonized latex beads to 
stain with a lysotracker 28 in fibroblasts doubly deficient for LAMP-1 and LAMP-2.  
A specific role of LAMP-2 in autophagosome fusion has also been suggested but 
decisive proof is lacking. 22 
 
LAMP-2 is a heavily glycosylated type-1 membrane protein with three splice variants, 
LAMP-2A, LAMP-2B and LAMP-2C. 5, 16 The three isoforms consist of a common 
heavily glycosylated extracellular domain linked to a single membrane spanning 
domain and a short cytoplasmic tail that includes a lysosomal/endosomal targeting 
signature and differs between the three isoforms. 4, 24 Over the past decade LAMP-2 
has been recognized to make an important contribution to an increasing number of 
cellular processes. Some functions appear to be shared by all isoforms - for example 
antigen presentation, 63 cholesterol trafficking, 51 lysosome biogenesis 13 and 
phagocytosis 28 – whilst others are isoform specific. Thus, the essential role of 
LAMP-2 in chaperone-mediated autophagy (CMA) is unique to LAMP-2A 7; only 
LAMP-2B contributes to retention of TAPL in the lysosomal membrane 9; and 
RN/DNautophagy is mediated exclusively by LAMP-2C. 18, 19 Human and murine 
cells deficient in LAMP-2 have increased numbers of autophagosomes, 12, 53 but 
although previous methods such electron microscopy allow the identification of 
autophagosomes and autolysosomes, they could not quantify autophagic flux 
precluding analysis of fusion. 
 
Transfection of cells with a LC3 construct fused to an mRFP and EGFP (tfLC3) 
tandem fluorescent tag identifies autophagosomes and autolysosomes and clearly 
distinguishes between them. 36 We have used this construct to establish that LAMP-2 
deficient mouse fibroblasts have a major defect in the degradation of autophagosomal 
content within the lysosome that is reversed by complementation with LAMP-2A but 
not LAMP-2B.  Remarkably, LAMP-2 deficiency did not affect the expression of the 
lysosomal R-SNARE VAMP8 but instead reduced the abundance of autophagosomal 
STX17 to near undetectable levels, and altered recruitment of the accessory proteins 
required for tethering and fusion. These results identify a novel function for LAMP-2 
and have obvious implications for understanding the mechanisms of autophagosomal 
maturation and degradation and the consequences of LAMP-2 deficiency.  
 
 
Results 
 
LAMP-2 deficiency inhibits macroautophagy 
We first established the conditions for the induction of autophagy in a well-
characterized set of SV40 transformed mouse embryonic fibroblast (MEF) cell lines 
derived from mice singly deficient in LAMP-2, doubly deficient in LAMP-1 and 
LAMP-2, and wild-type littermates and analyzed the contribution of LAMP-2 to 
autophagosome-lysosome fusion. 14 All three cell lines expressed the Simian virus 40 
(SV40) large T antigen (Fig. S2A) and LAMP-1 and LAMP-2 were undetectable by 
immunofluorescence and Western blotting in the appropriate deficient cells line (Fig. 
S2B, S2C). The MEF cell lines were then transiently transfected with tandem-tagged 
LC3 (tfLC3/mRFP-EGFP-LC3) (Fig. 1A) and autophagosomes that had incorporated 
tfLC3 were identified by orange fluorescence (co-localisation mRFP/EGFP) that 
distinguished them from autolysosomes that fluoresce red (mRFP) because of 
quenching and digestion of the EGFP when exposed to lysosomal acidity and 
enzymes (Fig. S2D). 36 This enabled us to assess the formation and the maturation of 
newly synthesized autophagosomes.  
 
In wild-type MEF, induction of autophagy after 6 hours incubation with rapamycin 
(Fig. 1B) or Hank’s balanced salt solution (HBSS) (Fig. 1C) caused parallel 
increases in autophagosomes and autolysosomes: autophagosomes - 4.15±2.89 to 
10.29±6.61 (p<0.0001) and 9.00±7.78 (p<0.01) puncta/cell pre- and post-rapamycin 
and HBSS respectively; autolysosomes - 2.70±4.37 to 9.96±8.31 (p<0.0001) and 
14.35±14.30 puncta/cell (p<0.0001) pre- and post-rapamycin and HBSS (Fig. 1D). 
Rapamycin and HBSS caused the expected increase in autophagosomes in LAMP-2 
deficient MEF but without change in the number of autolysosomes (autophagosomes 
- 3.47±2.65 to 11.00±6.13 and 3.47±2.65 to 12.41±6.95 pre- and post-rapamycin and 
HBSS respectively; and autolysosomes - 5.47±4.67 to 3.05±4.21 and 6.95±6.68) (Fig. 
1E). The results with LAMP-1/2 doubly deficient MEF were identical (Fig. 1F). 
Incubation with rapamycin or HBSS for 4 hours produced similar results (Fig. S3A, 
S3B), thus confirming the failure to generate autolysomes in LAMP-2 deficient MEF 
and implying a reduction in autophagic flux.  
 
We confirmed the influence of LAMP-2 on autophagic flux using Western blot to 
examine endogenous concentrations of LC3-I and LC3-II and p62/sequestosome 1 
(p62/SQSTM1), a targeting molecule incorporated into autophagosomes and 
degraded in autolysosomes. Under resting conditions, LC3-I and LC3-II were more 
abundant in the lysates from LAMP-2 deficient MEF than wild-type cells. Incubation 
with rapamycin slightly increased the level of LC3-II in wild-type cells and the effect 
was exaggerated in LAMP-2 deficient cells, consistent with the failure to degrade 
LC3 II (Fig. 1G). Similarly, concentrations of p62/SQSTM1 decreased in wild-type 
MEF after rapamycin treatment but remained unchanged in LAMP-2 deficient cells, 
indicating the failure to increase autophagic flux. Collectively, the data establish that 
LAMP-2 deficient cells have impaired autophagic flux characterized by a selective 
reduction in autolysosomes. This locates the defect at a late stage of the autophagic 
process.  
 
Reconstitution with LAMP-2A restores the wild-type phenotype 
Next we used human LAMP-2 cDNA constructs to establish that absence of LAMP-2 
was responsible for the defect in autophagosome fusion and that the human protein 
was able to rescue endogenous mouse LAMP-2 deficiency. To confirm the functional 
efficacy of the LAMP-2 constructs, cell lines were transiently transfected with a 
photoswitchable CMA reporter construct, pKFERQ-PS-CFP2 37 (Fig. 2A) which, 
after photoconversion, identifies lysosomes that have imported the reporter protein by 
LAMP-2A-dependent CMA as green fluorescent puncta. There were few green 
fluorescent puncta in wild-type MEF incubated in complete medium, indicating a low 
basal level of CMA, but these increased greatly after 24 hours incubation in HBSS 
(Fig. 2B, S4A). By contrast, HBSS failed to increase the number of green puncta in 
either LAMP-2 deficient (Fig. 2B, S4B) or LAMP-1/2 doubly deficient MEF (Fig. 
2B, S4C), demonstrating their inability perform CMA (Table S1). The efficacy of the 
LAMP-2A construct was then evaluated by its ability to restore CMA in the deficient 
cell lines. This was done by transiently co-transfecting the cell lines with the 
photoswitchable CMA reporter construct and LAMP-2A; the effectiveness of 
transfection was confirmed by immunofluorescence (Fig. S4D). Complementing with 
LAMP-2A completely restored the defect in CMA (Fig. 2C) (Table S2) and 
therefore confirms the functional efficacy of the construct. This enabled us to test 
whether restoring LAMP-2 expression was equally effective at overcoming the defect 
in autophagy. 
 
LAMP-2 deficient MEF were co-transfected with tfLC3 and either LAMP-2A (Fig. 
2D) or LAMP-2B (Fig. S5A) and expression of the transgene was confirmed by 
indirect immunofluorescence. Using an antibody specific for hLAMP-2, the results 
were compared to those obtained with uncomplemented LAMP-2 deficient MEF (Fig. 
2E) and wild-type MEF (Fig. 2F). As with CMA, complementation with LAMP-2A 
rectified the defect in autophagy as demonstrated by the concomitant increase in 
autophagosomes and autolysosomes after rapamycin treatment, both in LAMP-2 
single and LAMP-1/2 doubly deficient MEF (Fig. 2G). Autophagic flux induced by 
HBSS was similarly restored (Fig. 2H). By contrast, reconstitution with LAMP-2B 
did not rescue the autophagic flux which confirms a specific role for LAMP-2A in 
autophagy (Fig. S5B, Fig. S5C) (Table S3) (Table S4). However due to an absence 
of a control confirming a physiological role of the LAMP-2B construct we cannot 
definitively exclude a possible role in autophagy. 
 
LAMP-2 deficient cells have normal lysosome numbers and VAMP8 expression 
LAMP-2 is a major lysosomal membrane protein but its deficiency in the MEF cell 
lines, either alone or together with LAMP-1, had no effect on the number or location 
of lysosomes visualized with lysotracker under resting conditions and after induction 
of autophagy with rapamycin or HBSS (Fig. 3A, Fig. 3B) (Table S5). We next 
examined whether LAMP-2 deficiency influenced the abundance of the lysosomal 
SNARE VAMP8.  
 
After rapamycin treatment, there was a non-significant increase of VAMP8 in the cell 
lysates from double deficient cell lines compared to wild-type and LAMP-2 -/- MEF  
(Fig. 3C, Fig. 3D). Despite this, the number of VAMP8 positive puncta was similar 
in all three cell lines, both before and after induction of autophagy with either 
rapamycin or HBSS for 6 hours (Fig. 3E, Fig. 3F) (Table S6) or for 4 hours (Fig. 
S6A). VAMP8 co-localized with LAMP-1 indicating it was restricted to lysosomes 
(Fig. S6B, Fig. S6C) but was not detected on LC3 positive autophagosomes (Fig. 
S6D, Fig. S6E). The specific localization of VAMP8 was confirmed by immune-
electron microscopy (Fig. 3G, Fig. S6F) where co-localization between the 
lysosomal marker LAMP-1 (15nm gold particle) and VAMP8 (5nm gold particle) 
was observed in both cell lines (Fig. S6G). The ratio between VAMP8 and LAMP-1, 
established by counting 5 and 15 nm gold particles inside LAMP-1 positive vesicle 
was increased non-significantly in LAMP-2 deficient cells under resting conditions 
and after autophagy induction. This effect was due to an increased number of 
VAMP8 particles as LAMP-1 remains unchanged (1.167± 0,377 LAMP-1 particle/ 
LAMP-1 + vesicles in wild-type and 1.303± 1.075 LAMP-1 particle/ LAMP-1 + 
vesicles in LAMP-2 deficient cell) (Fig. S7A).  Interestingly intact VAMP8 positive 
lysosome-like structures were seen inside autophagosomes of LAMP-2 and LAMP-
1/2 deficient MEF (Fig. S7B). These structures also expressed LAMP-1 confirming 
they were lysosomes that had been incorporated during the engulfment stage. 
Engulfed lysosomes were not observed in wild-type MEF but found uniquely in 
single and doubly deficient cells, either because LAMP-2 deficient lysosomes are 
especially susceptible to autophagy or because of the reduced autophagic flux.  
 
The results were identical regardless of whether autophagy was induced by HBBS or 
rapamycin making it highly unlikely that the LAMP-2 dependent defect in autophagy 
can be explained by an effect on VAMP8. Accordingly, we examined the effect of 
LAMP-2 deficiency on expression of STX17, VAMP8’s interacting partner on 
autophagosomes.  
 
LAMP-2 deficiency prevents STX17 localisation to autophagosomes 
LAMP-2 deficiency had no effect on the abundance of STX17 in whole cell lysates 
from MEF by Western blot (Fig. 4A, Fig. 4B), and, as described by Itakura E. et al., 
2012, 30,33 it translocated to LC3+ autophagosomes in wild-type cells after induction 
of autophagy (Fig. 4C). Strikingly, in the absence of LAMP-2, the number of STX17 
positive puncta visualized by immunocytochemistry was markedly reduced (Fig. 4D). 
This difference, already apparent in resting cells was far greater after incubation with 
rapamycin in which STX17 positive vesicles increased in wild-type MEF but not in 
the LAMP-2 deficient cell lines (Fig. 4D, Fig. 4E)(Table S7). We confirmed that 
LAMP-2 deficient cells are unable to recruit STX17 to autophagosomes by 
transfecting cells with Flag-tagged STX17. Ectopic expression of human STX17 
(FLAG STX17) did not rescue STX17 translocation to LC3 positive autophagosomes 
(Fig. 4F) whereas reconstitution with LAMP-2A partially restored the number of 
STX17 positive puncta (Fig. 4G, Fig. 4H) (Table S8). However, the increase was 
less than in wild-type cells, possibly due to the unstable expression levels of LAMP-
2A after transient transfection, or alternatively because of the absence of the two 
other LAMP-2 isoforms.   
 
These results established for the first time a role of LAMP-2 in STX17 recruitment 
and were further confirmed by absence of STX17 co-localization on LC3 positive 
autophagosomes (Fig. 5A) as well as on LAMP-1 positive vesicles (Fig. 5B) in 
LAMP-2 deficient MEF. In wild-type MEF, STX17 was localized to LC3 positive 
vesicles (Fig. 5C) and also to rare LAMP-1 positive vesicles (Fig. 5D). Co-
localization of STX17 with LC3 was significantly lower in LAMP-2 deficient cells 
both under resting conditions and after autophagy induction (Fig. 5E)(Table S9) 
while overlapping of STX17 with LAMP-1 was very low in both cell lines indicating 
the rare presence of STX17 on LAMP-1 positive vesicles (Fig. 5F) (Table S10). The 
localization of STX17 was confirmed by immune-electron microscopy, however 
STX17 positive autophagosomes were rare in singly and doubly deficient fibroblasts 
(Fig. 5G). Rare co-localization was observed between LAMP-1 (15nm gold particle) 
and STX17 (5nm gold particle) positive vesicles in wild-type MEF (Fig. 5H) 
whereas the ratio STX17 particle/LAMP-1 particle was increased in LAMP-2 
deficient cells treated with rapamycin (Fig. S7C). This was due to an increased 
number of STX17 particles, as the number of LAMP-1 particles remained unchanged 
(1.444±1.054 LAMP-1 particle/LAMP-1+ vesicles in wild type and 1.221± 0.518 
LAMP-1 particle/ LAMP-1 + vesicles in LAMP-2 deficient cell). Moreover, the 
autophagosomes of LAMP-2 and LAMP-1/2 deficient MEF also contained STX17 
positive lysosome-like structures (Fig. S7D) which also expressed LAMP-1, and 
appeared identical to those observed with VAMP8 ((Fig. S7B).  Taking this 
observation into account, a ratio was established by quantifying the number of 
STX17 particles per LAMP-1 positive vesicles in lysosome like structures and in 
normal vesicles. In LAMP-1 positive lysosome like structure, the number of STX17 
particles was significantly increased in LAMP-2 deficient cells after autophagy 
induction (Fig. S7E) while in intact vesicles the ratio was similar in each cell line 
independent of the treatment (Fig. S7F). Thus LAMP-2 deficiency severely reduces 
STX17 expression on autophagosomes and this provides a potential mechanism for 
their failure to fuse with lysosomes. 
 
LAMP-2 deficiency prevents SNAP-29 localisation to autophagosomes 
SNAP-29 complexes with STX17 on the surface of autophagosomes and enhances 
fusion by binding VAMP8 on lysosomes. 30, 52, 59 SNAP-29 positive puncta were rare 
in wild-type MEF under resting conditions and did not co-localize with LC3 (Fig 6A, 
Fig 6B) (Table S11). After induction of autophagy, their number increased markedly 
and co-localization with LC3 was obvious (Fig. 6C) whereas co-localization with 
LAMP-1 was rare (Fig. 6D). By contrast, SNAP-29 positive puncta were 
significantly more common in LAMP-2 deficient MEF under basal conditions but 
were unaffected by rapamycin treatment (Fig. 6A, Fig. 6B). SNAP-29 did not co-
localize with LC3 (Fig. 6E) but occasional co-localization with LAMP-1 was 
observed and slightly increased after induction of autophagy (Fig. 6F) as confirmed 
by quantification of co-localization. By measuring co-localization we also confirmed 
that the overlapping of SNAP-29 with LC3 was decreased non-significantly in the 
absence of LAMP-2 (Mander’s overlapping coefficient: 0,077±0,023 and 
0.055±0,028 in wild-type treated with FCS and rapamycin-0.032±0.017 and 
0.034±0.038 in LAMP-2 deficient cells pre- and post-rapamycin treatment). Thus, 
autophagosomes in LAMP-2 deficient MEF fail to recruit SNAP-29 as well as 
STX17.  
 
VPS33A does not co-localize with LC3 in LAMP-2 deficient MEF 
The HOPS complex also binds to STX17 on autophagosomes and tethers them to 
Rab7 on lysosomes 33, 39 prior to fusion. 58 Accordingly, we investigated the influence 
of LAMP-2 deficiency on Rab7 and the HOPS complex subunit Vacuolar protein 
sorting-associated protein 33A (VPS33A). The three cell lines contained similar 
numbers of Rab7 positive puncta (Fig. S8A, Fig. S8B) that also expressed LAMP-1 
(Fig. S8C, Fig. S8D); Rab7 did not co-localize with EGFP-LC3 (Fig. S8E, Fig. S8F). 
As previously reported, Rab7 positive vacuoles were restricted to the perinuclear 
regions of wild-type and LAMP-2 deficient MEF 14, 30 but were more diffusely 
distributed in the LAMP-1/2 doubly deficient cells (Fig. S8A). Thus, Rab7 retains its 
normal expression in lysosomes/late endosomes in LAMP-2 singly deficient MEF. 
 
Under resting conditions, VPS33A partially co-localized with LAMP-1 (Fig. 7A) and 
had a similar perinuclear distribution in wild-type and LAMP-2 deficient MEF (Fig. 
7B). In wild-type MEF, treatment with rapamycin induced a partial redistribution of 
VPS33A from LAMP-1 expressing vacuoles to LC3 positive autophagosomes (Fig. 
7C) but this did not occur in LAMP-2 deficient MEF (Fig. 7D) in which co-
localization of VPS33A and LC3 was reduced, albeit not significantly (Mander’s 
overlapping coefficient: 0.115±0.075 and 0.105±0.080 in wild-type treated with FCS 
and rapamycin-0.070±0.063 and 0.082±0.042 in LAMP-2 deficient cells pre- and 
post-rapamycin treatment). By contrast, treatment with rapamycin increased co-
localization between VPS33A and LAMP-1 in the LAMP-2 deficient cells (Fig. 7E) 
This provides further confirmation of the functional consequences of the lack of 
STX17 on autophagosomes. 
Discussion 
LAMP-2 deficient cells contain increased numbers of autophagosomes but it has 
been unclear whether this is due to increased generation or their failure to fuse with 
lysosomes. 13, 22 Using tandem fluorescent-tagged LC3, we now show unequivocally 
that autophagosomes in LAMP-2 deficient mouse fibroblasts fail to fuse with 
lysosomes, and that the defect can be reversed by complementation with LAMP-2A, 
although it remains uncertain whether the other two isoforms would be similarly 
effective. Mechanistically, LAMP-2 deficiency reduces expression of 
autophagosomal SNARE STX17 to nearly undetectable levels without change in the 
abundance of its lysosomal partner, VAMP8, thus providing a reason for the impaired 
fusion (Fig. S9). These results identify the translocation of SNARE proteins to 
autophagosomes as a previously unsuspected function for LAMP-2 with implications 
not only for individuals with Danon disease who are genetically deficient of LAMP-2 
but also for situations, such as aging, where LAMP-2 expression is reduced.  
 
Cells from individuals (Danon disease) 48 and mice 53 with genetic LAMP-2 
deficiency have increased numbers of autophagosomes in vivo. LAMP-2 deficient 
cells in vitro also have increased numbers of autophagosomes but the respective 
contribution of enhanced or sustained formation and decreased fusion have not been 
clearly defined. 13, 22, 41 The principal difficulty has been to quantify the formation and 
the maturation of the autophagosomes because endogenous or GFP-tagged LC3 is 
immediately destroyed or quenched by lysosomal enzymes and pH after fusion and is 
thus rendered invisible. 36 Additional data from electron microscopy and biochemical 
analysis of LC3 have not proved decisive and assays for the autophagy substrate 
SQSTM1/p62 were not yet available. 2, 13, 28 The development of the dual tagged tfLC3 
construct 36 resolved these difficulties since its mRFP red component continues to 
fluoresce within lysosomes, enabling to determine whether autophagosomal cargo 
has been degraded. This allowed us to show clearly that autophagosomal degradation 
was severely inhibited in the absence of LAMP-2, and to confirm this was associated 
with reduced autophagic flux by immunoblotting for SQSTM1/p62. The defect was 
equally severe in LAMP-2 singly deficient and LAMP1/2 doubly deficient cells, 
strongly suggesting that LAMP-2 was responsible. This is supported by the fact that 
the defect was reversed by complementation with LAMP-2A at levels that also 
restored CMA, although this does not preclude contributions from other LAMP-2 
isoforms.  
 
The recent elucidation of the central components of the machinery responsible for 
autophagosome–lysosome fusion provided the opportunity to examine the reasons for 
its failure in LAMP-2 deficient cells. Fusion depends on binding of the Qa-SNARE 
STX17 on the autophagosomal membrane to the lysosomal R-SNARE VAMP8 30 in 
an interaction that requires the Qbc-SNARE SNAP-29 and results in the tetrameric 
trans-SNARE complex. The respective location of STX17 and VAMP8 to 
autophagosome and lysosome was first confirmed by immune-electron microscopy. It 
was a surprise that deficiency of a lysosomal protein such as LAMP-2 should 
radically reduce STX17 expression on autophagosomes with normal, or possibly even 
raised VAMP8 expression on lysosomes. The absence of STX17 translocation to the 
autophagosomes was further supported by a reduction of STX17 co-localization with 
LC3 both under resting conditions and after induction of autophagy. Due to the 
increased numbers of autophagosomes after rapamycin treatment, co-localization of 
STX17 and LC3 remains unchanged under both conditions in wild-type cells. 
Moreover, complementation with LAMP-2A partially restores the defect, thus 
confirming the functional connection between LAMP-2A and STX17. However, we 
detected less effect of LAMP-2 deficiency on relocation of the STX17 interacting 
partners SNAP-29 and VPS33A to the LC3+ autophagosomes. This could either be 
due to technical reasons resulting from background staining with the antibodies used; 
or alternatively because even in the absence of their high affinity partner STX17, 
SNAP-29 and VPS33A still bind to the surface of autophagosomes, albeit less 
efficiently. Despite a limited effect, the reduction of the Qbc SNARE SNAP-29 and 
HOPS complex component VPS33A on the autophagosomes supports the role of 
STX17 in recruiting them and identified the autophagosome as the major site of the 
defect. In the absence of STX17 on autophagosomes, SNAP-29 may interact and 
saturate its other binding partner VAMP8, explaining its lysosomal localization in 
LAMP-2 deficient cells. Due to saturation, induction of autophagy could not further 
enhance the recruitment of SNAP-29, leading to an increased number of SNAP-29 
positive puncta pre- and post- rapamycin treatment. Collectively these results prove 
that LAMP-2 is required for normal translocation of STX17 to autophagosomes 
providing the mechanism for their failure to degrade autophagosomal content. 
 
LAMP-2 is not expressed by autophagosomes and its deficiency did not influence the 
whole cell content of STX17. Accordingly, LAMP-2 must be critical for 
translocating STX17 to autophagosomal membranes, or for its retention there. In 
resting cells, it has been suggested that STX17 is found freely in the cytoplasm and in 
the endoplasmic reticulum but translocates to mature autophagosomes utilizing a 
glycine zipper-like motif in its transmembrane domain that integrates into the double 
membrane. 30 Membrane STX17 then recruits O-GlcNAcylated SNAP-29 whose 
availability is controlled by O-glycosylation transferase (OGT). 25 SNAP-29 also 
interacts with syntaxin 6 forming a SNAP-29/Stx6 SNARE complex that may 
regulate autophagy. 25 The STX17/SNAP-29 complex is further stabilized by the 
incorporation of the dimeric form of Atg14 11 which also primes its interaction with 
VAMP8 to promote membrane fusion. 11 Finally, the HOPS complex may also 
stabilize the heterodimers STX17/SNAP-29. 33 However, control of STX17’s origin 
or availability remained unclear.  
 
LAMP-2 is a major component of the lysosomal limiting membrane 5, 13 and has 
important roles in maintaining its integrity, and for transporting proteins, 13 nucleic 
acids 18 and cholesterol across it. 14, 15, 62 LAMP-2 is absolutely required for CMA 
which targets long-lived proteins for degradation 7, 41 including inhibitors of T cell 
receptor signaling which is attenuated in the absence of LAMP-2A 56: analogous 
degradation of putative inhibitors of STX17 translocation would provide a potential 
explanation. Alternatively, abrogation of LAMP-2 dependent export of cholesterol 
from late endosomes and lysosomes reduces cholesterol concentrations in the 
endoplasmic reticulum, 51 which is known to alter recruitment of syntaxin 6. 50 This in 
turn could affect its interaction with SNAP-29 and thus its availability to interact with 
STX17. 34 Moreover, low levels of cholesterol in the ER and increased lysosomal 
cholesterol found in LAMP-2 deficient cells induce the interaction of the cholesterol 
sensor ORP1L with the ER protein VAP-A which prevents tethering and fusion. The 
ORP1L induced contact sites can modulate autophagosomes maturation and therefore 
potentially STX17 recruitment. 61 More experiments are needed to test these 
possibilities. 
 
Leakage of lysosomal membranes and release of lysosomal hydrolases represent a 
potentially harmful situation for cells and damaged lysosomes may be specifically 
degraded by autophagy (lysophagy) as a protective measure. 27, 40 Our data also 
indicate that LAMP-2 may play a role in lysophagy. The presence of LAMP-1 
positive lysosomes embedded into autophagosomes of LAMP-2 deficient cells 
suggests either a potential role of LAMP-2 in the maintenance of the lysosomal 
quality and integrity or a direct contribution to autophagy-mediated-lysosome 
turnover. 
 
In conclusion, we have shown that LAMP-2A has a critical role in recruitment to 
autophagosomes of STX17 and its co-factors SNAP-29 and VPS33A and thus of 
fusion with lysosomes. This extends the function of LAMP-2A to include 
macroautophagy as well as CMA. Regardless of the mechanism, our results provide a 
new insight into the consequences of LAMP-2 deficiency in Danon disease. They 
also have implications for more common situations in which LAMP-2 concentrations 
are reduced sufficiently to impair its function, notably in the elderly; 8, 45, 56 and in 
individuals with autoantibodies to LAMP-2 and small vessel vasculitis. 35, 49 
 
Material and methods: 
 
Plasmids: The pEGFP-LC3, the ptfLC3 and the FLAG-Stx17 construct have been 
acquired from Addgene (Addgene plasmid 21073, Addgene plasmid 21074 and 
Addgene plasmid 45911). The generation of these constructs has been previously 
described. 30, 34, 36  
The generation of the photoswitchable reporter pKFERQ-PS-CFP2 has been 
described by Koga et al. 37 The following oligonucleotides, 
5’ctagcgccaccatgaaggaaactgcagcagccaagtttgagcggcagcacatggactccagcacttccgctgcg 3' 
and  
5’gatccgcagcggaagtgctggagtccatgtgctgccgctcaaacttggctgctgcagtttccttcatggtggcg 3’ 
were directly annealed and ligated into the NheI and the BamHI sites of the pPS-
CFP2-N vector (Evrogen, FP802, Moscow, Russia). This sequence is coding for 21 
amino acids of the ribonuclease A (MKETAAAKFERQHMDSSTSAA)(Accession 
number  AAB35594). 
The LAMP-2A sequence (Accession number  NP_002285) was designed by 
GENEART GmbH using the GeneOptimizerTM software.The coding sequence (0 to 
1233) was based on the sequence information described by Fukuda et al. 20 It 
comprises 1233 nucleotides and is bordered by 5’ggatccggagatctggggaagtctgcggggtc 
3’ and 5’ctcgagggttgcagatt 3. This introduces a BamH1 site at the 5’ end and a Xho1 
site at the 3’end (underlined). These restrictions sites were used to extract the LAMP-
2A fragment and clone it into the respective cloning site of pcDNA3 (Invitrogen, 
Carlsbad, CA, USA). 
The LAMP-2B construct (Accession number NP_054701) from bases -3 to 1233 was 
amplified from a LAMP-2B construct kindly provided by Dr. Friedrich Haag. The 
PCR product generated with the primers 5’ggatccgtcatggtgtgcttccgcctcttcccg 3’ (-3 to 
24) and  5’ttacagagtctgatatccagcataa 3’ (1208 to 1233) was subcloned into PCR 2.1 
cloning vector using the TA cloning kit (Invitrogen K2040-01, Carlsbad, CA, USA) 
according to the manufacturer instructions. The Xho1 and Kpn1 released fragment 
was then cloned into the respective cloning sites of pcDNA3. 
 
Cells culture and transfection: WT, LAMP-2 -/- and LAMP-1/2 -/- MEF were a 
kind gift of Prof. Dr. Paul Saftig (Department of Biochemistry at the Christian-
Albrechts Universität Kiel, Germany). Their generation was reported previously. 14 
We uniquely selected cell lines immortalized by transfection with a plasmid 
containing the SV-40 large T antigen. Cells were cultured in Dulbecco’s modified 
Eagles medium (DMEM) (Gibco, Waltham, MA, USA) supplemented with 10% fetal 
calf serum (Gibco, Waltham, MA, USA) and 1% penicillin/streptomycin (Gibco, 
Waltham, MA, USA).  
MEF were transfected using Lipofectamine 2000 (Invitrogen, 11668019, Carlsbad, 
CA, USA), Fugene 6 (Promega, E2691, Madison, WI, USA) according to the 
manufacturer instructions. Transfection of the FLAG-Stx17 construct into MEF was 
performed using Lipofectamine 3000 (ThermoFisher, L3000008, Waltham, MA, 
USA) following manufacturer’s instructions. 
 
Autophagy induction: Autophagy was induced by starvation or treatment with an 
mTOR inhibitor rapamycin (50uM) (Calbiochem, 553210, San Diego, CA, USA) for 
0, 4 and 6 hours. For starvation, cells were washed 3 times with Phosphate buffered 
saline (PBS) and incubated in HBSS (Invitrogen, 14025-092, Carlsbad, CA, USA). 
Rapamycin treatment was added to fresh DMEM after 3 washings with PBS.  
For LC3 immunostaining, rapamycin treatment was combined with chloroquine 
(30µM) (Sigma, C6628, St. Louis, MI, USA). 
 
Live cell imaging:  MEF transfected with the photoswitchable reporter pKFERQ-PS-
CFP2 were cultured in µ-Slide Angiogenesis (IBIDI, 81506, Planegg, Germany). The 
photoconversion was carried out with a confocal laser scanning microscope (Lsm 780, 
Carl Zeiss, Oberkochen, Germany) by applying a 405nm diode laser, 30mW, 63X 
objective. The photoswitching time did not exceed 5 seconds in plane mode. The 
photoconversion did not affect the viability of the cells (Data not shown). After 
treatment pictures of the cells were acquired using confocal laser scanning 
microscope (Lsm 780, Carl Zeiss, Oberkochen, Germany) equipped with 63X 1.4NA 
oil objective lens, a Diode laser 405nm and an Argon laser, Multiline, 458nm, 488nm, 
514nm, at 37C and 5% CO2. Pictures were analyzed with the ZEN 2010 software and 
the quantification was done with FIDJI software. Both the photoswitching and the 
imaging were performed in phenol red free media. 
 
Immunostaining and confocal microscopy: MEF were seeded on µ-Slide 
Angiogenesis (IBIDI, 81506, Planegg, Germany) or on µ-Slide 8 well (IBIDI, 80826, 
Planegg, Germany). After treatment with media, HBSS or rapamycin the cells were 
washed with PBS and fixed with freshly prepared 4% paraformaldehyde. MEF 
transfected with FLAG-Stx17 were fixed and permeabilized with ice-cold methanol 
(10 min) followed by incubation with ice-cold acetone for 1 min.  After washing with 
PBS, cells were permeabilized (Table S12 and S13), blocked with 10% goat 
serum/1% donkey serum for 30 min at room temperature and incubated with primary 
antibody diluted in 1% goat serum/1% donkey serum overnight at 4°C or 1h00 at 
room temperature (Table S12 and S13) Similar diluent without primary antibody 
was used as negative control. After 3 washings with PBS, secondary antibody, 
diluted in goat/donkey serum 1% was added to the cells for 1h00 at room temperature 
(Table S12 and S13). In some staining, DAPI was used to visualize the nuclei. Cells 
were stored in 0.4% paraformaldehyde and analyzed using a confocal laser scanning 
microscope (Lsm 780, Carl Zeiss, Oberkochen, Germany) using ZEN 2010 or ZEN 
2012 software. This microscope was equipped with 63X 1.4NA oil objective lens, a 
Diode laser 405nm, an Argon laser, Multiline, 458nm, 488nm, 514nm, a DPSS-Laser 
561nm, a HeNE-Laser 594nm and a HeNe-Laser 633nm. Images analysis and 
quantification were performed using the software FIDJI. 
 
Light microscopy: MEF were cultured in 4-well chamber slides. Cells were fixed in 
freshly prepared 4% paraformaldehyde and stained in a Benchmark Ultra Fa Ventana 
(Roche, Basel, Switzerland). The following protocol was used: primary antibody 32 
min, hematoxylin 4 min and detection with the Universal DAB Detection Kit 
(Ventana, 760-500, Basel, Switzerland). 
Pictures were acquired using an Axio Scope A1 microscope with a X40 objective 
equipped with an Axiocam ICc3 digital camera and an Axiovision analysis software. 
 
Immunoelectron microscopy: MEF were seeded and cultured in Nunc Cell culture 
Petri dishes. The fixation was performed in freshly prepared 4% paraformaldehyde 
and 0.1% glutaraldehyde in 0.1M phosphate buffer for 2h00. After 3 washings with 
PBS, agarose pellets were made (1% agarose in 0.1M Phosphate buffer) and fixed in 
4% paraformaldehyde and 0.1% glutaraldehyde in 0.1M phosphate buffer for 30 min. 
The cells were then dehydrated in ascending alcohol sequence and embedded in 
acrylic resin Lowicryk K4M (Polysciences, 15923, Warrington, PA, USA). After 
blocking with 1% chicken egg albumin, ultrathin sections were treated with rat anti-
mouse LAMP-1 clone 1DB4 (Developmental Studies Hybridoma Bank, Iowa City, 
IA, USA) and/or Rabbit anti-VAMP8 (HPA006882, Sigma, 1:10, St. Louis, MI, 
USA) or Rabbit anti-STX17(HPA001204, Sigma, 1:5, St. Louis, MI, USA) for 2h00. 
After 3 washings in 0,1% chicken egg albumin in 0.1M Tris, cells were incubated for 
1h00 with Goat Anti-Rabbit IgG conjugated to colloidal gold (15nM) 
(BBInternational, EM.GAR15, Cardiff, UK) and doubly stained with 2% uranyl 
acetate (Ted Pella, Inc., 19481, Redding, CA, USA) and lead citrate. For double 
staining, Goat Anti-Rabbit IgG conjugated to colloidal gold particle of 5nM and Goat 
Anti-Rat IgG conjugated to colloidal gold particles of 15nM were used.  Sections 
were examined with a JEOL JEM-1200EX transmissions electron microscope. 
 
Quantitative immunoelectron microscopy was performed by counting the number of 
colloidal gold particles (5 and 15 nM). All quantifications were done by an observer 
blinded to experimental conditions. 
 
Western blot:  Expression of LAMP-1, LAMP-2, actin, VAMP8 and STX17 was 
analyzed in MEF homogenates. Cells were collected in PBS after trypsinization, 
sedimented by spinning, resuspended in lysis buffer (125mM Tris-HCl pH 6.8/4% 
SDS/20% glycerol/200mM DTT) and subjected to sonication. After heating 5 min at 
95°C, protein fraction of MEF was separated by a 10% SDS-PAGE (LAMP-1 and 
LAMP-2) or by a 10-20% Ready Gel Tris-HCL (Biorad, 161-1160, Hercules, CA, 
USA) and transferred onto a polyvinylidene difluoride membrane. After blocking for 
1h00 at room temperature, the blot was incubated overnight at 4°C with primary 
antibody. Membranes were washed 3 times for 5 min with TBS-Tween (0.05%) and 
incubated with alkaline phosphatase coupled antibody for 1h00 at room temperature. 
After incubation with the DuoLux chemiluminescence substrate (Vector Laboratories, 
SK 6604, Burlingame, CA, USA)  the signal was analyzed  using the Lumi-Imager 
F1. Image processing and western blot quantification were done by using the FIDJI 
software. Results represent the quantification of at least 4 independent experiments 
and are expressed as relative to the level of the housekeeper protein actin.  
 
Antibodies:  The following primary antibodies has been used in this study: rat anti 
mouse LAMP-1 (clone 1DB4, Developmental Studies Hybridoma Bank, Iowa City, 
IA, USA), 28 rat anti-mouse LAMP-2 (clone ABL-93, Developmental Studies 
Hybridoma Bank, Iowa City, IA, USA), 13, 51 Rabbit anti-SNAP-29 (Sigma, 
HPA031823, St. Louis, MI, USA) which specificity has been extensively 
characterized by the Human Protein Atlas, Rabbit anti-VAMP8 (Sigma, HPA006882, 
St. Louis, MI, USA) (characterized by the Human Protein Atlas), Rabbit anti-
syntaxin17 (Sigma,  HPA001204, St. Louis, MI, USA) (characterized by the Human 
Protein Atlas), 11, 33,  46  Rabbit anti-VPS33A [C1C3] (GeneTex, GTX 119416, Taiwan, 
ROC)57, Goat anti- MAP LC3α/β (F-14, sc-16756, Santa Cruz,Dallas, TE, USA) 
(Immunofluorescence), 21, 54, 55  Mouse Anti-SV-40 Monoclonal Antibody (Cell 
Marque, 351M-17, Rocklin, CA, USA), Human LAMP-2 (clone H4B4, 
Developmental Studies Hybridoma Bank, Iowa City, IA, USA), 49 Rabbit anti-actin 
(Sigma, A2066, St. Louis, MI, USA), 42 Rabbit anti-p62 (Cell signaling, 5114, 
Danvers, MA, USA), 17 Rabbit anti-LC3B (Cell signaling, 2775) (Western blot), 64 
Rabbit anti-Rab7 (Immunofluorescence) (Cell signalling, 9367, Danvers, MA, USA), 
32 Rabbit anti-FLAG (Sigma, F7425, St. Louis, MI, USA). 6, 23 
 
For immunofluorescence we used the following secondary antibodies: Alexa Fluor 
488 Goat anti-rat IgG (Invitrogen, A-11006, Carlsbad, CA, USA), Alexa Fluor 546 
Goat anti-rat IgG (Invitrogen, A-11081, Carlsbad, CA, USA), Alexa Fluor 488 Goat 
anti-rabbit IgG (Invitrogen, A-11008, Carlsbad, CA, USA), Alexa Fluor 647 Goat 
anti-rabbit IgG (Invitrogen, A-21244, Carlsbad, CA, USA), Alexa Fluor 405 Goat 
anti-mouse IgG (Invitrogen, A-31553, Carlsbad, CA, USA), Alexa Fluor 546 Goat 
anti-mouse IgG (Invitrogen, A-11003, Carlsbad, CA, USA), Alexa Fluor 594 Donkey 
anti-rabbit IgG (ThermoFisher, A-21207, Waltham, MA, USA), Alexa Fluor 488 
Donkey anti-goat IgG (ThermoFisher, A-11055, Waltham, MA, USA). 
 
Anti-rat IgG-AP conjugate (Promega, S3831, Madison, WI, USA) and Anti-rabbit 
IgG-AP conjugate (Promega, S3738, Madison, WI, USA) were used for Western blot. 
 
Quantification of lysosomes:  Lysosomes were labeled with Lysotracker 
(Lysotracker Red DND-99. Invitrogen, L7528, Carlsbad, CA, USA). Briefly, the 
cells, cultured in a µ-slide angiogenesis (IBIDI, 81506, Planegg, Germany) were 
treated with rapamycin or HBSS for 0, 4 and 6 hours. Then 50nM of lysotracker was 
added to the media for 30 min at 37°C and the cells were fixed in freshly prepared 
4% paraformaldehyde in PBS. The number of lysosomes was evaluated using a 
particle counting plugin in FIDJI software. 
 
Image analysis: Positively transfected cells were identified by eyes. 
For each quantification, a region of interest of one cell was delineated including the 
cytoplasm and excluding the nucleus. All quantifications were performed by an 
observer blinded to experimental conditions. 
Quantification of mRFP/EGFP colocalization was performed by using the plugin 
“Coloc 2”on the FIDJI software. 
The number of EGFP positive and mRFP positive puncta observed after transfection 
with ptfLC3 were quantified using the function 3D Object Counter v2.0 on the FIDJI 
software. Similar size filter was applied through the whole experiment while the 
threshold was determined individually by a blinded experimentator; the transient 
transfection leading to various level of expression.  
The number of EGFP positive puncta in fibroblast transfected with the 
photoswitchable reporter pKFERQ-PS-CFP2 was counted by eyes. 
Quantification of the positive vesicles stained with a lysotracker or by 
immunofluorescence was operated by a counting plugin with filters for threshold and 
size, adapted for each experiment. Similar filters were applied for each condition 
inside each experiment. 
 
Quantitative co-localization analysis evaluating the proportion of SNAP-
29/STX17/VPS33A colocalizing with LAMP-1/LC3 was performed over the entire 
fluorescence images using the Fidji’s plugin “JACoP” (Just Another Colocalization 
Plugin). 3 
 
Statistical analysis: The statistical significance of the CMA experiment was 
evaluated by a one-way ANOVA followed by a student’s t-test. The other 
experiments were analyzed using a non-parametrical Kruskal-Wallis test followed by 
a Mann-Whitney test when appropriate. Values are presented as mean±SD. All 
statistical calculations were performed using the GraphPad software. 
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Figure legends: 
 
Figure 1: The autophagic flux is impaired in LAMP-2 single and LAMP-1/2 doubly 
deficient cells after autophagy induction. Cells were transfected with the tandem-
fluorescent tagged mRFP-GFP-LC3 construct (A) and cultured in media (control), 
rapamycin (50µm) (B) or HBSS (C) for 6h00. In wild-type MEF, autophagy 
induction was characterized by an increased number of autophagosomes and 
autolysosomes (D) while in LAMP-2 single deficient (E) and LAMP-1/2 doubly 
deficient (F) cells the number of autolysosomes remained unchanged after treatment 
with rapamycin or HBSS. (G) Western blot analysis of total cell extract reveals an 
absence of degradation of p62 after rapamycin treatment confirming the blockage of 
the autophagic flux in LAMP-2 negative cells. Scale bar = 10µm. *, P<0.05; **, 
P<0.01***; P<0.001; ****, P<0.0001 (Mann-Whitney test). 
 
Figure 2: CMA and autophagic flux are restored by LAMP-2A. CMA, monitored 
with the photoswitchable reporter pKFERQ-PS-CFP2 (A) could be efficiently 
induced in wild-type cells but not in LAMP-2 single and LAMP-1/2 doubly deficient 
MEF indicating their inability to conduct CMA (B). This process was efficiently 
restored by transfection with LAMP-2A (C). Similarly, Reconstitution of LAMP-2 
deficient cells with LAMP-2A (D) restored the increase of autolysosomes after 
induction of autophagy. Results were compared to LAMP-2 deficient (E) and wild-
type MEF (F) and reveal a restoration of the autophagic flux after treatment with both 
rapamycin (G) or HBSS (H). Scale bar = 10µm. Data are expressed as mean±SD of 3 
independent experiments. *, P<0.05; **, P<0.01***; P<0.001; ****, P<0.0001 
(Mann-Whitney test). 
 
Figure 3: Lysosomal parameters are not altered in the absence of LAMP-2. 
Lysosome numbers are similar in all three cell lines as is the pattern of distribution 
after treatment (A-B).  Expression of VAMP8 is not statistically significantly 
increased in LAMP-1/2 doubly deficient cells (C-D). A similar number of vesicles 
was observed in all cell types independent of the type of method used to induce 
autophagy (E-F). Scale bar = 20µm. Immunoelectron microscopy confirms the 
localization of VAMP8 in the lysosomes of LAMP-2 sufficient and deficient cells 
grown in media or rapamycin. Scale bar = 500nm (G). Data are expressed as 
mean±SD from at least 15 cells in each condition and are representative of 3 
independent experiments. 
 
 Figure 4: STX17 is not found on the autophagosomes of LAMP-2 and LAMP-1/2 
deficient cells. The amount of protein in the cell lysate of LAMP-2 deficient and 
sufficient cells is similar (A-B) while the localization of STX17 is different. In wild-
type cells, STX17 is recruited to LC3 positive autophagosome after autophagy 
induction (C), but it is not observed on the autophagosomes of single and doubly 
deficient cells (D-E).  Transfection of wild-type and LAMP-2 deficient cells with the 
FLAG-Stx17 construct confirms the absence of STX17 recruitment into vesicles in 
the absence of LAMP-2 (F) (Scale bar = 20µm). This effect could be partially 
restored by transfection with LAMP-2A (G-H) (Scale bar = 20µm). Data are 
expressed as mean±SD of 3 independent experiments. **, P<0.01; ****, P<0.0001 
(Mann-Whitney test) 
 
 
 
Figure 5: Localization of STX17 is affected in the absence of LAMP-2. In LAMP-2 
negative fibroblast, STX17 could not be detected on either LC3 positive 
autophagosomes (A) or on LAMP-1 positive vesicles (B). In wild-type MEF, STX17 
is mainly present on the autophagosomes as indicated by co-localization with LC3 
(C) and occasionally on LAMP-1 positive lysosomes (D). Scale bar = 20µm. Using 
the JACoP plugin, a significant decrease of co-localization of STX17 with LC3 was 
observed in the absence of LAMP-2 (E), while the overlapping of STX17 with 
LAMP-1 was absent in both cell types (F).   Immune-electron microscopy confirms 
the autophagosomal localization of STX17 in wild-type MEF (G). Due to the low 
number of STX17 positive particles definitive localization could not be established in 
LAMP-2 single and LAMP-1/2 doubly deficient cells (G) (Scale bar = 500nm). 
LAMP-1 and STX17 were observed in independent vesicles in wild-type MEF (H) 
(Scale bar = 200nm). Data are expressed as mean±SD from at least 15 cells in each 
conditions and is representative of 3 independent experiments. **, P<0.01; ****, 
P<0.0001 (Mann Whitney test). 
 
 
Figure 6: Quantity and localization of SNAP-29 positive vesicles are altered in the 
absence of LAMP-2. Under basal conditions more SNAP-29 positive vesicles were 
observed in the absence of LAMP-2 (A-B). In wild-type MEF, SNAP-29 co-localized 
with EGFP- LC3 positive vacuoles (C) and occasionally with LAMP-1 (D). In 
LAMP-2 deficient cells, co-localization with LC3 positive vacuoles (E) was not 
observed while co-localization between LAMP-1 and SNAP-29 was rare (F). Scale 
bar = 20µm. Data are expressed as mean±SD of 3 independent experiments. ***; 
P<0.001(Mann-Whitney test). 
 
Figure 7: VPS33A is affected by the absence of LAMP-2. VPS33A partially co-
localized with LAMP-1 in wild-type MEF (A) observed as a perinuclear staining also 
in LAMP-2 deficient cells but absent in LAMP-1/2 double deficient MEF (B). After 
treatment with rapamycin VPS33A co-localized with EGFP-LC3 in wild-type (C) but 
not in LAMP-2-/- MEF (D) where co-localization with LAMP-1 was increased (E). 
Scale bar = 20µm. 
 
 
 
 







